Survival of metastatic melanoma patients after dendritic cell vaccination correlates with expression of leukocyte phosphatidylethanolamine-binding protein 1/Raf kinase inhibitory protein

Sonja Buschow; M Ramazzotti; IMJ Reinieren-Beeren; LM Heinzerling; H Westdorp; I Stefanini; L Beltrame; S V Hato; E Ellebaek; S Gross; VA Nguyen; G Weinlich; J Ragoussis; D Baban; B Schuler-Thurner; IM Svane; N Romani; JM Austyn; IJM de Vries; G Schuler; D Cavalieri; CG Figdor

doi:10.18632/oncotarget.18698

Survival of metastatic melanoma patients after dendritic cell vaccination correlates with expression of leukocyte phosphatidylethanolamine-binding protein 1/Raf kinase inhibitory protein

Sonja Buschow, M Ramazzotti, IMJ Reinieren-Beeren, LM Heinzerling, H Westdorp, I Stefanini, L Beltrame, S V Hato, E Ellebaek, S Gross, VA Nguyen, G Weinlich, J Ragoussis, D Baban, B Schuler-Thurner, IM Svane, N Romani, JM Austyn, IJM de Vries, G SchulerD Cavalieri, CG Figdor

Gastroenterology & Hepatology

Research output: Contribution to journal › Article › Academic › peer-review

13 Citations (Scopus)

3 Downloads (Pure)

Original language	Undefined/Unknown
Pages (from-to)	67439-67456
Number of pages	18
Journal	Oncotarget
Volume	8
Issue number	40
DOIs	https://doi.org/10.18632/oncotarget.18698
Publication status	Published - 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.18632/oncotarget.18698

Survival_of_metastatic_melanoma_patients_after_den.pdfFinal published version, 3.97 MB

http://hdl.handle.net/1765/104675

Cite this

Buschow, S., Ramazzotti, M., Reinieren-Beeren, IMJ., Heinzerling, LM., Westdorp, H., Stefanini, I., Beltrame, L., Hato, S. V., Ellebaek, E., Gross, S., Nguyen, VA., Weinlich, G., Ragoussis, J., Baban, D., Schuler-Thurner, B., Svane, IM., Romani, N., Austyn, JM., de Vries, IJM., ... Figdor, CG. (2017). Survival of metastatic melanoma patients after dendritic cell vaccination correlates with expression of leukocyte phosphatidylethanolamine-binding protein 1/Raf kinase inhibitory protein. Oncotarget, 8(40), 67439-67456. https://doi.org/10.18632/oncotarget.18698

@article{827605287c1b41c4aca7930cc605864e,

title = "Survival of metastatic melanoma patients after dendritic cell vaccination correlates with expression of leukocyte phosphatidylethanolamine-binding protein 1/Raf kinase inhibitory protein",

author = "Sonja Buschow and M Ramazzotti and IMJ Reinieren-Beeren and LM Heinzerling and H Westdorp and I Stefanini and L Beltrame and Hato, {S V} and E Ellebaek and S Gross and VA Nguyen and G Weinlich and J Ragoussis and D Baban and B Schuler-Thurner and IM Svane and N Romani and JM Austyn and {de Vries}, IJM and G Schuler and D Cavalieri and CG Figdor",

year = "2017",

doi = "10.18632/oncotarget.18698",

language = "Undefined/Unknown",

volume = "8",

pages = "67439--67456",

journal = "Oncotarget",

issn = "1949-2553",

publisher = "Impact Journals LLC",

number = "40",

}

Buschow, S, Ramazzotti, M, Reinieren-Beeren, IMJ, Heinzerling, LM, Westdorp, H, Stefanini, I, Beltrame, L, Hato, SV, Ellebaek, E, Gross, S, Nguyen, VA, Weinlich, G, Ragoussis, J, Baban, D, Schuler-Thurner, B, Svane, IM, Romani, N, Austyn, JM, de Vries, IJM, Schuler, G, Cavalieri, D & Figdor, CG 2017, 'Survival of metastatic melanoma patients after dendritic cell vaccination correlates with expression of leukocyte phosphatidylethanolamine-binding protein 1/Raf kinase inhibitory protein', Oncotarget, vol. 8, no. 40, pp. 67439-67456. https://doi.org/10.18632/oncotarget.18698

Survival of metastatic melanoma patients after dendritic cell vaccination correlates with expression of leukocyte phosphatidylethanolamine-binding protein 1/Raf kinase inhibitory protein. / Buschow, Sonja; Ramazzotti, M; Reinieren-Beeren, IMJ et al.

In: Oncotarget, Vol. 8, No. 40, 2017, p. 67439-67456.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Survival of metastatic melanoma patients after dendritic cell vaccination correlates with expression of leukocyte phosphatidylethanolamine-binding protein 1/Raf kinase inhibitory protein

AU - Buschow, Sonja

AU - Ramazzotti, M

AU - Reinieren-Beeren, IMJ

AU - Heinzerling, LM

AU - Westdorp, H

AU - Stefanini, I

AU - Beltrame, L

AU - Hato, S V

AU - Ellebaek, E

AU - Gross, S

AU - Nguyen, VA

AU - Weinlich, G

AU - Ragoussis, J

AU - Baban, D

AU - Schuler-Thurner, B

AU - Svane, IM

AU - Romani, N

AU - Austyn, JM

AU - de Vries, IJM

AU - Schuler, G

AU - Cavalieri, D

AU - Figdor, CG

PY - 2017

Y1 - 2017

U2 - 10.18632/oncotarget.18698

DO - 10.18632/oncotarget.18698

M3 - Article

VL - 8

SP - 67439

EP - 67456

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 40

ER -